Refined Diagnostics
PrivateLast Round
VC Round
Jul 7, 2026
Total Funding Raised
$2.94M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Refined Diagnostics operates in Healthcare & Life Sciences and is based in Münster. Its latest recorded funding round was a VC Round in July 2026.
Refined Diagnostics is a medical technology company that develops laser-based imaging systems for real-time, stain-free cancer diagnostics and tissue analysis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Biotech Equipment, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Refined Diagnostics Comparables
Compare Refined Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Invenio Imaging | 91% | |
| illumiSonics Inc. | 86% | |
| Flash Pathology | 84% |
For institutional investors. Book with your work email.
Refined Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 7, 2026 | ||||
| Seed | Jan 26, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Refined Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Onsight Ventures | Seed |
| APEX Ventures | Seed |
| NRW.Bank | Seed |
| High-Tech Gründerfonds | Seed |
| Companisto | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 11, 2026
Added Klinikum Bayreuth GmbH, a mid-market healthcare provider.
- Jul 7, 2026
$3.3M round led by Companisto
For institutional investors. Book with your work email.
Refined Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Refined Diagnostics's valuation, stock price, and market status.
Is Refined Diagnostics a public or private company?
Refined Diagnostics is a private company.
What is the current stock price of Refined Diagnostics?
Refined Diagnostics is a private company, so its shares have no public market price. Caplight tracks Refined Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Refined Diagnostics worth (valuation)?
Valuation information for Refined Diagnostics is not publicly available.
Can I buy Refined Diagnostics stock?
Refined Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Refined Diagnostics's last funding round?
Refined Diagnostics's most recent funding round was VC Round on July 7, 2026.
Who are the main investors in Refined Diagnostics?
Key investors in Refined Diagnostics include APEX Ventures, High-Tech Gründerfonds, Companisto.
Will Refined Diagnostics IPO soon?
No public IPO plans have been announced for Refined Diagnostics.
How can I track Refined Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Refined Diagnostics's shares on secondary markets.